Glenmark Life Sciences Ltd. is a leading pharmaceutical company in India with a strong focus on ESG. They develop and manufacture high-quality active pharmaceutical ingredients for various health conditions such as cardiovascular disease, central nervous system disease, and diabetes. With an ESG score of 31.4, they are known for their sustainable practices in the industry.